Chemotherapy in epithelial ovarian cancer

Cancer Lett. 2011 Apr 28;303(2):73-83. doi: 10.1016/j.canlet.2011.01.026. Epub 2011 Feb 24.

Abstract

Epithelial ovarian cancer is the most common type of ovarian cancer; usually occurs in women older than 50years, and because 75% of cases are diagnosed at stage III or IV it is associated with a poor prognosis. Treatment of ovarian cancer is based on the integration of surgery and chemotherapy. Chemotherapy plays a major role both in the adjuvant treatment and in the care of patients with advanced disease. Several active drugs have been introduced in the treatment of ovarian cancer in the last decades and novel targets and agents are under evaluation.

Publication types

  • Review

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Drug Therapy / methods
  • Female
  • Humans
  • Medical Oncology / methods
  • Middle Aged
  • Ovarian Neoplasms / drug therapy*
  • Prognosis
  • Recurrence
  • Treatment Outcome

Substances

  • Antineoplastic Agents